xanomeline tartrate

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-1997
01219951997

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
The cognitive efficacy of the M1-selective muscarinic agonist xanomeline in mild-to-moderate Alzheimer disease (AD) was measured… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
OBJECTIVE To evaluate the therapeutic effects of selective cholinergic replacement with xanomeline tartrate, an m1 and m4… (More)
Is this relevant?
1995
1995
Xanomeline tartrate (active ingredient xanomeline) is a muscarinic agonist that has demonstrated specificity for the M1 receptor… (More)
Is this relevant?
1995
1995
1. In this double-blind, placebo-controlled phase I study of the safety/tolerance of two doses of xanomeline tartrate (100 mg and… (More)
Is this relevant?